Skip to main content
. 2024 Nov 12;16(11):1447. doi: 10.3390/pharmaceutics16111447

Table 2.

Kd of the complexes of albumin with modified oligonucleotides.

Modification Site of Modification Kd, μM References
graphic file with name pharmaceutics-16-01447-i001.jpg sugar backbone, 2′-OH >400 [145]
graphic file with name pharmaceutics-16-01447-i002.jpg inter-nucleotide phosphate 4–7 [145]
graphic file with name pharmaceutics-16-01447-i003.jpg 3′-end of ON 8–12 [145]
graphic file with name pharmaceutics-16-01447-i004.jpg 3′-end of ON 0.227 [124]
graphic file with name pharmaceutics-16-01447-i005.jpg 3′-end of ON 0.024 [124]
graphic file with name pharmaceutics-16-01447-i006.jpg 3′-end of ON 0.218 [124]
graphic file with name pharmaceutics-16-01447-i007.jpg 3′-end of ON 0.041 [146]
graphic file with name pharmaceutics-16-01447-i008.jpg inter-nucleotide phosphate 1.2–1.5 [130]
graphic file with name pharmaceutics-16-01447-i009.jpg 3′- and 5′ ends of aptamer 0.1–1 [147]